IKA Ultra Turrax Tube Drive UT TD S1 BioSystem Fixed Speed Homogenizer
IKA
Details
-
CategoryHomogenizer / Stirrer
-
Dimension7.0in x 4.0in x 2.0in
-
Serial03.312746
-
Shipping TypeFedEx Ground
-
ManufacturingDoes Not Apply
-
Voltage / Hertz120V/220V / 50Hz/60Hz
Description
This used IKA Ultra Turrax Tube Drive UT TD S1 BioSystem is a versatile homogenizer that functions as intended and is in very good condition with minimal cosmetic damage. Originating from the United States, this unit efficiently processes a wide range of sample materials. It is particularly suited for applications involving the dissolution of medications such as tablets or capsules, the dispersion and extraction of human, animal, and plant tissues, the emulsification of cosmetic samples, and the extraction of bacteria including E. coli. Operable at voltages of 120V/220V with a frequency of 50Hz/60Hz, this homogenizer provides reliable performance for both laboratory and pharmaceutical environments. The compact design, measuring just 7.0 x 4.0 x 2.0 inches and weighing 2.0 pounds, makes it an ideal choice for limited-space workstations.
Key Features
- Processes a wide range of sample materials
- Suitable for medication dissolution and tissue dispersion
- Operates on 120V/220V
- Compact and space-efficient design
- Includes power cord
Specifications
- Brand/Manufacturer: IKA
- Model: Ultra Turrax Tube Drive UT TD S1 BioSystem Fixed Speed
- Condition: Used, Very Good
- Voltage: 120V/220V
- Frequency: 50Hz/60Hz
- Applications: Medication dissolution, tissue dispersion, bacterial extraction
- Includes: Power cord
Weight
Imperial: 2.4 Pounds
Metric: 1.09 Kilograms
Shipping Dimensions
Imperial: 8.4 lb x 4.8 lb x 2.4 lb
Metric: 21.34 cm x 12.19 cm x 6.1 cm
Harmonized Code
84798200
Harmonized Code Details
84798200 - Machines and mechanical appliances having individual functions, not specified or included elsewhere; other machinery for mixing or kneading. This code reflects the machine's function as a homogenizer for laboratory use.
Comments 0
There are currently no public comments.